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ABSTRACT: Ligand ﬁeld molecular mechanics simulation
has been used to model the interactions of copper(II) and
platinum(II) with the amyloid-β1−42 peptide monomer.
Molecular dynamics over several microseconds for both
metalated systems are compared to analogous results for the
free peptide. Signiﬁcant diﬀerences in structural parameters
are observed, both between Cu and Pt bound systems as well
as between free and metal-bound peptide. Both metals
stabilize the formation of helices in the peptide as well as
reducing the content of β secondary structural elements
compared to the unbound monomer. This is in agreement
with experimental reports of metals reducing β-sheet
structures, leading to formation of amorphous aggregates
over amyloid ﬁbrils. The shape and size of the peptide
structures also undergo noteworthy change, with the free
peptide exhibiting globular-like structure, platinum(II) system
adopting extended structures, and copper(II) system resulting in a mixture of conformations similar to both of these. Salt bridge
networks exhibit major diﬀerences: the Asp23-Lys28 salt bridge, known to be important in ﬁbril formation, has a diﬀering
distance proﬁle within all three systems studied. Salt bridges in the metal binding region of the peptide are strongly altered; in
particular, the Arg5-Asp7 salt bridge, which has an occurrence of 71% in the free peptide, is reduced to zero in the presence of
both metals.
KEYWORDS: Amyloid-β peptide, copper, platinum, Alzheimer’s disease, ligand ﬁeld molecular mechanics,
ligand ﬁeld molecular dynamics
■ INTRODUCTION
Alzheimer’s disease (AD) is a neurodegenerative condition,
currently aﬀecting more than 30 million people worldwide,1,2
for which there is no cure. Common symptoms of AD include
short-term memory loss, mild cognitive impairment, confusion
and aggression. Over time, cognitive function degrades and
control of bodily functions is lost, eventually leading to death.
As a result, AD is the fourth most common cause of death in
Western countries.3
The causes and development of the condition are not well
understood, but AD is associated with damage to speciﬁc brain
regions, the hippocampus and cerebral cortex,4 involved in
memory and cognition. AD brains exhibit abnormal structures,
particularly deposits of neuroﬁbrillary tangles and plaques,5,6
formation of which is generally accepted to be the major
pathological identiﬁer of AD.7 Amyloid-β (Aβ) peptide was
ﬁrst recognized as the main component of the deposited
plaques in 19858 and has become the focus of much AD
research in the decades since. In addition, brains show
oxidative stress caused by reactive oxygen species (ROS)9,10
and increased concentrations of metal ions, such as copper,11
zinc,4,12 iron,13 and calcium.14
The amyloid hypothesis suggests that the buildup of Aβ in
the brain is the main cause of AD and that amyloids are the
main neurotoxic substance in disease progression. Individual
Aβ monomers aggregate, leading to plaque formation.15−18
This hypothesis suggests that Aβ possesses innate toxicity and
that plaque deposits indicate an overload of Aβ, leading to
disease.19,20 An imbalance of Aβ generation and clearance
leads to gradual accumulation of plaques in the brain.15−18
Thus, the formation of these plaques leads to a local
inﬂammatory response and subsequently to neuronal cell
death, leading to gradual cognitive decline.7,21 The rest of the
known disease process, including the formation of neuro-
ﬁbrillary tangles, would then occur from this imbalance of Aβ
generation and clearance.21,22
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The structure and chemistry of Aβ has been reviewed in
detail previously:4,23−26 in monomeric form, Aβ is an
intrinsically disordered peptide, adopting a random coil
structure in aqueous solution.27−29 Secondary structure and
toxicity depend strongly on chemical conditions: in water, Aβ
is reported to contain between 5% and 20% helical content and
0−25% β-sheet content, though the peptide remained mostly
“random coil” in nature, as seen in PDB models 2LFM,27
1AML,28 1BA4,30 and others.25 In general, the C-terminus of
Aβ is considered to form an extended helix-type structure. It
has been shown that soluble oligomeric forms of Aβ are more
toxic than mature plaques;16,18,20 these oligomeric forms of Aβ
are now increasingly believed to be the key toxic species in
AD.31−34 This structural variation poses challenges for
studying Aβ, as identifying relevant conformations of the
monomer is critical to understanding the oligomerization and
aggregation process.21,24
Metal ions are known to play an important role in AD:
disease progression correlates with the breakdown of Cu/Zn/
Fe homeostasis in the brain.4,35−37 These metals play a key role
in the formation and stability of amyloid aggregates, and in the
subsequent toxicity of Aβ. Increased levels of Cu(II) and
Zn(II) are found in plaque regions of diseased brain,38,39 and
plaques which do not contain metal ions have been found to
be nontoxic.40 In addition, the redox activity of Cu(II) and
Fe(II) indicate a possible mechanism for damage to brain cells,
via generation of ROS.41,42 As a result, the role of the natural
metal ions in AD is increasingly studied, and are reviewed
extensively elsewhere.4,12,13,25,26 Recently, a new hypothesis
has been put forward, suggesting a physiological role for the Aβ
monomer as a metal binding and transport vehicle that acts to
protect the brain from oxidative stress that results from
elevated levels of metal ions.23
A great deal of experimental work, supplemented by
extensive simulation, has elucidated details of metal−Aβ
coordination. The hydrophilic N-terminal region of Aβ
contains high-aﬃnity metal binding sites, particularly the
histidine (His)-rich region at residues 1−16. Varied metal
coordination sites, including N-terminal histidines (His6,
His13, and His14) and several oxygen ligands, such as alanine
(Ala2), aspartic acid (Asp7), glutamic acid (Glu3, Glu11), and
tyrosine (Tyr10) residues43−46 have been proposed.
Copper(II) binds to Aβ through three N-donors and one O-
donor (3N1O), with the speciﬁc choice of ligands being pH
dependent: the predominant coordination modes are shown in
Figure 1. These diﬀerent binding modes, or components, have
been experimentally resolved using continuous wave EPR
spectroscopy on smaller fragments of Aβ.43,47 Component I,
which binds through Asp1, His6, and His13/14 is present at
lower pH, approximately 6.5, whereas Component II binds
through Ala2, His6, His13, and His14, and is the predominant
form at higher pHs, approximately 7.4.
One possible route to AD-therapeutics involves disrupting
the coordination of the native metal ions using compounds
that selectively occupy the transition metal binding sites,
hindering aggregation. This approach was pioneered by
Barnham et al.,48 who showed that Pt(II)(phenanthroline)Cl2
complexes form adducts with Aβ bound through imidazole
side chains of His6, and either His13 or His14. These
complexes inhibit Aβ ﬁbril formation and generate amorphous
Aβ aggregates rather than ﬁbrils. Pt(II)(phen) complexes also
suppress hydrogen peroxide production by Cu(II)-Aβ42, and
Aβ toxicity in mouse neuronal cell cultures. Importantly, these
complexes are not toxic at the concentrations required to
produce this restorative eﬀect. Work by Ma and co-workers
showed that Pt(II)-Aβ binding at [Nε
H6,Nε
H14] predominates,
while no coordination to His13 was detected.49,50 In addition,
Streltsov et al. used a combination of EXAFS and DFT to
probe the local binding environment at Pt(II) and derive
structural models for the interaction of Pt(II)(phen)
complexes with Aβ16 and Aβ42.
51
DFT and ab initio methods have been used to investigate
copper-Aβ interactions, but their computational expense
typically requires the use of model systems such as Cu−
Aβ1−16 or smaller.
52,53 In addition, hybrid quantum mechanics/
molecular mechanics (QM/MM) was applied to Cu−Aβ1−16
to model energetics and redox potentials of diﬀerent Cu-
binding modes.54,55 QM/MM combined with homology
modeling was carried out by Ali-Torres et al.54 to probe the
Cu(II)−Aβ1−16 coordination sphere. The 3N1O model was
considered with His6, His13 and His14 as nitrogen ligands,
including δ and ε binding modes, with a range of potential
residues for the oxygen ligand. A comparison of implicitly
solvated free energy calculations revealed the most stable
complex to contain the backbone carbonyl oxygen of the Ala2
residue (component II). This result was also in agreement with
the experimental EPR results of Barnham and co-workers.44
These calculations conﬁrmed the preferential histidine binding
modes to be [Oc
A2,Nε
H6,Nδ
H13,Nε
H14].
Classical molecular dynamics simulations have also been
used to study Cu−Aβ complexes. Raﬀa and Rauk56 used DFT
optimizations of model structures to benchmark Cu(II)
parameters, which were used to study interaction with
Aβ1−42 monomers and the eﬀect of metal binding on secondary
structure. Cu(II) was bound via water, His13, His14 and
backbone N/O ligands; equilibration was observed after 350
ns, after which peptide structure was found to be dependent on
the metal coordination mode. Huy et al.57 used microsecond
molecular dynamics simulations to model the structure and
dynamics of Cu−Aβ1−42 monomer and dimer. Cu(II) was
coordinated to His6, His13 (or His14), and Asp1 with
distorted planar geometry. Cu(II) parameters were obtained
from small model systems via UB3LYP calculations in implicit
solvent. Pseudoequilibration of the metal-peptide complex was
reached after several hundred nanoseconds of simulation; this
revealed signiﬁcant changes in the peptide salt-bridge and
hydrogen-bond network upon Cu(II) coordination, as well as
changes in peptide secondary structure and radius of gyration.
Ligand ﬁeld molecular mechanics (LFMM)58−60 is a
powerful tool for the study of these transition metal-
biomolecule interactions, able to provide “the ﬂexibility and
generality of quantum mechanics with the speed of molecularFigure 1. Copper(II) binding modes to the N-terminus of Aβ.
ACS Chemical Neuroscience Research Article
DOI: 10.1021/acschemneuro.8b00210
ACS Chem. Neurosci. 2018, 9, 2795−2806
2796
mechanics”.61 Here the Ligand Field Stabilization Energy
(LFSE) in these complexes is captured in a small number of
transferable parameters. LFMM has seen success in modeling a
range of Jahn−Teller active Cu(II) systems,62 spin states of Ni
and Fe complexes63 and Pt(II)-biomolecule studies.64,65
Recently, we have shown the suitability of LFMM for
description of binding of Cu(II)66 and Pt(II) with fragments
of Aβ.67−69
In this work, we extend this LFMM approach to examine the
dynamical behavior of Cu(II)− and Pt(II)(phen)−Aβ
complexes using molecular dynamics simulations and LFMM
description of metal coordination coupled with conventional
molecular mechanics (MM) for the peptide.
■ RESULTS AND DISCUSSION
Conformational databases for the Aβ42, Cu(II)−Aβ42, and
Pt(II)−Aβ42 systems (denoted AB, Cu and Pt, respectively)
generated from LowMode molecular dynamics simulations
were used to select starting structures for use in the ligand ﬁeld
molecular dynamics (LFMD) simulations. Three distinct low
energy conformations (i.e., with mutual root-mean-square
deviation (RMSD) greater than 1.5 Å) were chosen for each
system, to enable better sampling of conformational phase
space. LFMD simulations of 1 μs were carried out for each
starting point, denoted 1−3, preceded by AB, Cu, and Pt, for
Aβ42, Cu(II)-Aβ42, and Pt(II)-Aβ42, respectively.
Aβ peptides are intrinsically disordered, such that full
equilibration is beyond current computational capabilities.
Therefore, we have utilized the description of quasi-
equilibration reported by Huy et al.,57 who used RMSD
ﬂuctuations around a stable value after several hundred
nanoseconds as their criteria to determine equilibration. Use
of several trajectories with diﬀerent starting points that have
been quasi-equilibrated allows for greater analysis of phase
space. Figure 2 shows RMSD for three microsecond
trajectories of each of AB, Cu, and Pt. Quasi-equilibration
times taken from these data were 0.30, 0.10, and 0.40 μs for
AB1, AB2, and AB3; 0.20, 0.30, and 0.10 μs for Cu1, Cu2, and
Cu3; and 0.25, 0.25, and 0.40 μs for Pt1, Pt2, and Pt3,
respectively. These assignments are supported by radius of
gyration (Rg) across the trajectories, which are reported in the
Supporting Information.
Trajectories beyond equilibration were used for further
analysis to compare the structural and dynamical diﬀerences
between the free Aβ and peptides coordinated with Cu(II) and
Pt(II). The data obtained for each trajectory has been
averaged, over representative number of frames, for eﬀective
comparison between the three systems of interest. Average
RMSD, along with standard deviation, maximum, and
minimum values, is reported in Table 1. Low standard
deviation values are observed, particularly for AB and Cu,
further supporting our assignment of equilibration times. Pt3 is
the only trajectory resulting in a standard deviation greater
than 1 Å, although this is within the range to be considered
quasi-equilibrated.57
Radius of gyration, Rg, quantiﬁes the size and compactness
of a peptide: data reported in Table 2 shows how metal
coordination aﬀects the size of Aβ. On average, the free Aβ
peptide is the most compact of the three systems, with a mean
value of 9.62 Å and a standard deviation across three
trajectories of 0.66 Å. This average value compares reasonably
well with values obtained from ion mobility cross sections
measurements of 10 to 15 Å.70 Pt trajectories are also quite
Figure 2. RMSD (Å) against initial structure of each trajectory, against time (μs) for AB (a), Cu (b), and Pt (c).
Table 1. RMSD (Å) of AB, Cu, and Pt
avg RMSD SD max min
AB1 4.12 0.08 4.56 3.75
AB2 19.15 0.16 19.71 18.71
AB3 15.79 0.11 16.22 15.20
Cu1 16.39 0.58 17.56 14.98
Cu2 6.77 0.23 7.93 5.78
Cu3 4.92 0.13 5.40 4.42
Pt1 10.86 0.34 12.18 8.55
Pt2 1.033 0.94 12.30 8.24
Pt3 12.55 1.09 15.23 8.70
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consistent, giving rise to more extended geometries and an
average Rg of 16.49 Å. The phenanthroline ligand also has
some contribution to this higher value, with a Rg of 2.29 Å,
when coordinated to just platinum. While, on average, the Pt
exhibits the least compact structure, the individual Cu
trajectories show that it occupies two distinct structural
conformations, with Rg values of 9.13/11.18, and 21.72 Å,
meaning that it occupies states similar to both the free peptide
and the platinated system.
Figure 3 reports the percentage secondary structure of the
AB, Cu, and Pt trajectories. One letter codes C, I, G, H, B, E,
and T correspond to the structure elements coil, π-helix, 310
helix, α-helix, β-bridge, β-sheet, and turn, respectively. As
expected for intrinsically disordered peptides, there is large
percentage of coil and turn structure for all three systems. AB
also exhibits 310 helical structures at residues Asp7-Gly9 and
Ser26-Ile31, in agreement with an experimentally resolved
structure of the related Aβ40 peptide in aqueous solution.
27 In
addition, several residues occupy β-bridge conformations for
signiﬁcant periods of simulation time and there is a small
occurrence of α-helix in the central hydrophobic region
(residues Leu17-Ala21) of the peptide.
Copper coordination induces signiﬁcant helical character,
both α- and 310- in nature, in the region of residues Asp23-
Leu34 and toward the C-terminus of the peptide, as shown by
a snapshot shown in Figure 4, as well as the prevalent turn and
coil structure. There is also helical character at residues Glu11-
Phe20, which centers on two of the coordinating residues
(His13 and His14), including a small amount of π-helix, which
is not present in either the free AB or Pt. Cu also exhibits a
signiﬁcantly smaller population of β-bridge conformations,
with only residues Ile32 and Val39 showing a minimal amount
of this.
As for free AB and Cu, there is a predominant occurrence of
turn and coil structure for the Pt. There is also 310 helical
character at several regions of this coordinated peptide,
including residues Glu3-Arg5, Val12-Lys16, and Ala30-Val36,
as shown by a snapshot in Figure 4. There is a mix of α- and
310-helix in Val18-Gly25, albeit with a lower occurrence than
the rest of the helical regions in this system. The C-terminus
also exhibits some β-bridge structures, albeit with lower
occurrence than AB, but greater than Cu.
The tertiary structure of each system has been mapped via
distances between Cα in each residue with all other Cα,
plotted as a heat map in Figure 5. The contact maps between
the residues is consistent with Rg values reported above. The
longer distances (shown as red) observed for Pt, especially in
the region of [(Asp1-Phe20), (Ala30-Val40)], show that on
average there is very little contact between the N- and C-
termini of the peptide, with distances between α-carbons
between 33 and 41 Å. The termini of the peptide, i.e. residues
1 to 23 and 29 to 42, remain fairly compact. Beyond the central
hydrophobic cluster, in the C-terminal direction, this system
exhibits an extended conformation, as shown by the sharp
increase in distance.
Cu exhibits a similar contact map, and therefore overall
structure, to Pt but with signiﬁcantly smaller distances between
the termini, as shown by larger green areas, corresponding to
distances of 20−29 Å. In contrast, AB shows a rather compact
structure, with the largest distances between α-carbons in the
region [(Tyr10-Phe20),(Met35-Val40)] with a maximum
distance of approximately 21 Å. The smaller distances between
the residues at N- and C- termini also show that this system
lacks any of the extended structure observed for Pt.
The numbers of hydrogen bonds for the three systems have
also been calculated and are reported in Table 3. On average,
the presence of coordinated metals reduces the number of
hydrogen bonds, as might be expected from the diﬀerences in
structure determined from results above. High standard
deviation values are observed throughout, alongside a large
range between minimum and maximum values for all systems,
suggesting that the hydrogen bonds are highly transient.
Figure 6 shows the root-mean-square ﬂuctuation (RMSF)
per residue of the three systems of interest, showing the
average mobility of the peptide backbone atoms across
trajectories. This data shows that AB generally has the lowest
RMSF values across the whole simulation time. Cu has
comparable values to AB, in general having slightly larger
RMSF values. Exceptions to this pattern are found for
coordinated residues (2, 6, 13, and 14), as well as the central
hydrophobic cluster (17−21). In contrast, Pt exhibits much
larger RMSF values across the whole sequence: this is even
true for residues that are bound to Pt (6 and 14). The residues
at the C-termini of the copper and platinum systems also show
much greater RMSF values than those at the N-termini,
whereas the free peptide has consistently low values across all
residues. Analysis of each individual trajectory can be found in
the Supporting Information: AB shows great consistency
across trajectories, whereas there is greater deviation between
trajectories for Cu and Pt.
At physiological pH, there are three positively charged and
six negatively charged residues in Aβ42, potentially leading to a
maximum of 18 salt bridges. The presence or absence of each
possible salt bridge have been calculated across all equilibrated
trajectory data. It should be noted that, due to the deﬁnition of
such contacts used in VMD, it is possible for a single residue to
form multiple salt bridge type interactions at the same time,
such that cumulative percentages for that residue can exceed
100%. Figure 7 shows averaged salt bridge contact maps for
AB, Cu, and Pt.
In AB, 13 of the possible salt bridges are observed, although
many are present for less than 50% of total simulation time.
Lys16-Glu11, Lys16-Glu22, and Arg5-Asp7 are present in
approximately 90% of frames, indicating that these residues
remain in close proximity throughout. In comparison, copper
coordination leads to fewer salt bridges, with only six occupied.
Once again, there is a recurrent Lys16−Glu11 interaction,
which is 100% present throughout the simulation. Arg5 forms
salt bridges with Glu22 and Asp23, contacts that are not
observed for the free peptide. However, this basic residue loses
Table 2. Radius of Gyration (Å) of AB, Cu, and Pt
avg Rg SD max min
AB1 9.07 0.04 9.27 8.90
AB2 9.43 0.14 9.83 8.91
AB3 10.73 0.09 11.19 10.15
all AB 9.62 0.66 11.19 8.90
Cu1 21.72 0.57 22.83 20.32
Cu2 11.18 0.21 12.04 10.28
Cu3 9.13 0.07 9.47 8.82
all Cu 13.78 5.53 22.83 8.82
Pt1 16.28 0.27 17.29 14.65
Pt2 15.51 1.05 17.82 13.35
Pt3 17.97 0.95 20.17 14.36
all Pt 16.49 1.29 20.17 13.35
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all contact with Glu3, Asp7, and Glu11 when Cu(II) binds,
showing that metal coordination signiﬁcantly disrupts the salt
bridge network at the N-terminus. Lys28 also shows fewer
interactions for Cu, only forming bridges with Asp1 and
Asp23.
Figure 3. Percentage secondary structure of AB (a), Cu (b), and Pt (c). C, I, G, H, B, E, and T correspond to the structure elements coil, π-helix,
310 helix, α-helix, β-bridge, β-sheet, and turn, respectively.
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Platinum binding also leads to signiﬁcant diﬀerences from
both free and copper coordinated systems. Once again,
coordination leads to loss of the Arg5-Asp7 salt bridge,
suggesting that coordination to His6 prevents formation of this
interaction. The Glu11-Lys16 contact, while still present, is
much less populated: again, metal coordination between these
residues apparently aﬀects the ability of the peptide to form
such a contact. Unlike Cu, Pt(II) complexation allows the
Lys16-Glu22 interaction to persist, as in the free peptide. The
platinated system also lacks the Lys28-Asp1 salt bridge, which
is present approximately 25% of the time in the other two
systems.
The extensive data gathered for all three systems allows for
further analysis of how the two diﬀerent metals aﬀect the
structure and dynamics of the peptide and allows for
comparison against the unbound system. RMSD and Rg data
show large variance in values between trajectories after
equilibration has been reached. This is particularly evident
for Cu, where Cu1 equilibrates to Rg of 22 Å, while Cu2 and
Cu3 equilibrate to 11 and 9 Å, respectively. This indicates a
signiﬁcant change in the compactness of the peptide between
trajectories. Further examination shows that Cu1 undergoes a
conformational change at approximately 0.1 μs, away from the
globular structure observed throughout trajectories Cu2 and
Cu3, to a more extended structure. Snapshots from the end of
each trajectory are reported in Figure 8a. The conformation
adopted by Cu1 is similar to that observed for all three Pt
systems, which have an average Rg value of 16.49 Å, (snapshots
shown in Figure 8b). Structures from the Cu2 and Cu3
trajectories show a greater similarity to those of the free
peptide, which have an average Rg value of 9.62 Å (Figure 8c).
The conformational change during Cu1 can also be easily
observed within the changing secondary structure over the
trajectory. The N- and C-termini are largely unchanged, but
signiﬁcant diﬀerences are observed after 0.1 μs for the central
portion of the sequence, Leu17 to Ala30, which is initially a
mix of turn and helix but becomes strongly coil like after the
conformational change. The hydrogen bonding network in
Cu1 includes contact between Glu22 and Ser28 that is
prevalent during the ﬁrst 0.1 μs, whereas after this point there
are no occurrences of this H-bond. Conversely, several H-
bonds are common after 0.1 μs, particularly Arg5-Asp23, Glu3-
Tyr10, and Glu11-Gln15, with occupancies of 86%, 76%, and
68%, respectively. These residues are not involved in any
signiﬁcant H-bonding in the Cu2 and Cu3 trajectories.
Figure 4. Selected snapshots of Aβ42 systems represented by ribbon
structures: (a) Cu and (b) Pt. White, green, blue, and pink sections
correspond to coil, turn, 310-helix, and α-helix, respectively. Copper
and platinum are shown as yellow and silver spheres, respectively.
Phen ligand is omitted for clarity.
Figure 5. Residue contact maps, based on α carbon distances (Å), of AB (a), Cu (b), and Pt (c).
Table 3. Hydrogen Bond Count for AB, Cu, and Pt
avg H-bond # SD max min
Aβ1 13.98 2.80 26 2
Aβ2 10.52 2.40 22 2
Aβ3 13.25 2.74 24 3
all Aβ 12.61 3.05 26 2
Cu1 9.34 2.49 20 1
Cu2 10.36 2.53 21 1
Cu3 10.12 2.74 25 1
all Cu 9.90 2.63 25 1
Pt1 11.64 2.49 23 2
Pt2 11.50 2.43 22 2
Pt3 8.97 2.36 19 0
all Pt 10.82 2.70 23 0
Figure 6. Root mean square ﬂuctuations (RMSF) of AB, Cu, and Pt.
Corresponding numerical data can be found in the Supporting
Information.
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DOI: 10.1021/acschemneuro.8b00210
ACS Chem. Neurosci. 2018, 9, 2795−2806
2800
Hydrogen bonding between Glu22 and Ser28, seems to have
some signiﬁcance in the overall structure of Cu, as in
trajectories Cu2 and Cu3 this interaction has an occupancy
of 62% and 43%, respectively.
Simulations on the free Aβ42 monomer in aqueous
conditions, with varying force ﬁelds and implementations,
have shown that coil dominates the ensemble, along with 5−
20% helical character and 0−15% β character.25 This is in good
agreement with results presented here (Figure 3) where we
ﬁnd helical and β-like populations of approximately 5% and
3%, respectively. However, turn-like structure dominates over
random coil here with populations of 69% and 23%,
respectively. This aligns with the work of Yang and Teplow71
who used extensive replica exchange MD simulations and
found that the expected random coil ensemble was separated
by regions of highly populated turn structure between residues.
They reported that, for nonterminal residues, that turnlike
structure contributed 30−80% of the overall peptide structure.
Within Cu, there is strong helical character, both α- and 310-
helix, in the central hydrophobic cluster and from Asp23
toward the C-terminus of the peptide, as shown by a snapshot
in Figure 8. There is also helical character at residues Glu11-
Phe20, which centers on two of the coordinating residues
(His13 and His14), including a small amount of π-helix, which
is not present in either AB or Pt. The copper system also
exhibits a signiﬁcantly smaller population of β-bridge
conformations, with only residues Ile32 and Val39 showing a
minimal amount of this. This is in agreement with available
experimental data, in that copper enables formation of
amorphous aggregates over amyloid ﬁbrils due to decrease in
β character.40 Our data is also in broad agreement with
previous simulation studies: Huy and co-workers57 found a
drop in β-structure from approximately 10% down to 0.6%
within Aβ42 upon copper coordination, which is similar to the
observed drop here of 3% to 0.4%. However, our longer
simulations ﬁnd an increase in helical character on copper
coordination, especially around the central hydrophobic cluster
and toward the C-terminus, compared to a slight reduction in
Huy et al.’s work.
As would be expected, metal coordination has a pronounced
eﬀect on the secondary structure of the peptide in the metal
binding region. Both Cu(II) and Pt(II) reduce the content of
β-bridge to zero and alter the residues that form helices. The
310-helix observed for residues Asp7-Gly9 is not present in
either metalated system, where it is entirely turn structure. This
is likely a result of metal binding to the neighboring His6
residue, breaking this structure element. There is also a
diﬀerence between the secondary structure of the metals’
coordination spheres: platinum results in a 310-helix at Glu3-
Arg5, compared with less than 3% of this structure in Cu. This
region is ﬂanked by two residues that both coordinate to
copper, where the platinum only has coordination to His6,
meaning that for copper there is less ﬂexibility to form diﬀerent
structural elements. A similar observation can be made for the
His13-His14 region, whereby copper binds to both and
Figure 7. Salt bridge contact maps, percentage occurrence, for AB (a),
Cu (b), and Pt (c). Corresponding numerical data may be found in
the Supporting Information.
Figure 8. Final frame of the trajectories for (a) Cu, (b) Pt, and (c)
AB.
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platinum only binds to the latter. For the copper binding
residues, some helical character is observed (ca. 12%) but the
remainder is turn dominated. Platinum once again exhibits a
mix of turn and 310-helix at the His14 residue, and none of the
other helical structure elements seen for copper. Beyond the
copper having two additional binding sites, the platinum’s
relatively bulky phen ligand is the major diﬀerence which, as
shown by RMSF and residue contact maps, gives a less
compact N-terminus and allows for greater ﬂexibility. These
diﬀerences are key in the diﬀerent peptide structural behavior
observed.
One of the more pronounced diﬀerences between the free
peptide and the metalated LFMD simulations is the content of
helical secondary structure elements. AB overall has an
occurrence of less than 5%, whereas Cu and Pt have helical
content of >19% and >16%, respectively. From these results, it
is clear that both metals stabilize helices within Aβ, which has
shown to potentially destabilize ﬁbril formation and instead
lead to amorphous aggregates.71 This also has other possible
implications in the progression of AD, where Kepp23 has
postulated that a loss of functional Aβ monomer is the root
cause of disease. Therefore, the stabilization of helices by
copper, along with maintaining the monomer’s biological
functions, suggests that copper does not exclusively contribute
to ﬁbril formation. Platinum also stabilizes helices, but
competition with copper at the metal-binding region may
impair monomer function.
RMSF data presented in Figure 6 shows that metal
coordination increases the mobility of the Aβ peptide. This
is particularly evident for Pt, which has the greatest RMSF
values across the entire peptide, with values peaking for
residues in the C terminus. A similar pattern is observed for
Cu, with residues past Leu34 having the highest RMSF values
for this system. The conformations exhibited by Pt and the
Cu1 trajectory provide some explanation of this, in that the
spatial separation of the peptide termini allows the C-terminus
to be more mobile. In comparison, the N-termini of the copper
and platinum systems are constrained by the metal
coordination, as shown by the lower RMSF values for the
coordinating residues. The more compact nature of the free
peptide systems leads to the lower RMSF values as well as the
even distribution of mobility across the entire peptide.
Comparing RMSF of the AB and Cu shows that
coordination results in greater mobility of the peptide
backbone with exceptions for the coordinating residues, due
to the restriction of the metal binding, and the central
hydrophobic cluster. Val24 also exhibits a marginally higher
RMSF for free peptide. The central hydrophobic cluster is
known to be important in ﬁbril formation, as contacts between
this region and the C-terminus have been found to destabilize
ﬁbrils and more likely result in amorphous aggregates.71 The
observation that Cu(II)-coordination reduces mobility of this
region might therefore suggest a role for metals in aﬀecting
oligomerization. The relatively bulky phenanthroline ligand on
the platinum, along with only two coordinating residues,
results in a less compact N-terminus compared to the copper
systems, with four coordinating residues. This can be observed
in the contact maps for residues in the N-termini in Figure 5.
The less compact nature of the platinum coordination site
allows for greater conformational ﬂexibility resulting in the
greater RMSF values seen for the platinated systems.
Figure 9 gives more detail on the eﬀect of metals on the
Asp23-Lys28 salt bridge, which is known to be important for
aggregation into ﬁbrils.72 AB shows a sharp peak around 4.0 Å,
and two broader peaks around 4.7 and 6.0 Å: no recorded
frame has a distance greater than 7 Å, such that even in
conﬁgurations not classiﬁed as containing this salt bridge the
residues remain in general proximity of one another. Copper
coordination increases the prevalence of close contacts, and
reduces the peak distance to around 3.5 Å. However, 30% of
conﬁgurations are also present where these residues are fully
separated at more than 20 Å apart. Platinum coordination is
broadly similar to Cu(II), with a sharp peak at shorter
separation than in the free system, but also with 67% of
conﬁgurations in which Asp23-Lys28 are more than 10 Å
apart.
As shown in Figure 7 above there is a salt bridge between
residues Asp5-Arg7 in the free peptide, with an occurrence of
71%, which is no longer present after coordination. Figure 10
shows the distance distribution of this salt bridge, for the three
systems, in greater detail. AB shows a sharp peak at
approximately 4 Å, with a smaller shoulder at 3.5 Å,
Figure 9. Asp23-Lys28 salt bridge distance distribution (Å) against
percent of occurrence.
Figure 10. ARG5-ASP7 salt bridge distance distribution (Å) against
% occurrence.
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corresponding to the presence of the salt bridge. The peak at
6.2 Å represents the 29% of the trajectories where this salt
bridge does not occur, but no frames are found where this
distance is greater than 7 Å. In contrast, both Cu and Pt
trajectories lack this salt bridge in all frames, with no distance
less than 9 and 7 Å, respectively. Figure 11 reports snapshots of
these systems, showing how metal coordination at His6 leads
to the side chains pointing away from each other, with no such
eﬀect in the free peptide. It seems clear, therefore, that metal
coordination to HIS6 must lead to loss of this salt bridge and
hence disruption of the structure of the N-terminus. This may
then have an eﬀect on the structure and aggregation of Aβ,
although these monomer simulations cannot yield any
information on this. These snapshots also suggest a role for
the phenanthroline ligand, which leads to a less compact, more
ﬂexible N-terminus, which may explain the closer contact of
Asp5 and Arg7 compared to Cu.
■ CONCLUSIONS
Analysis of the data extracted from the LFMD simulations
show that it is clear that coordination by copper and platinum
has a signiﬁcant and diﬀerent eﬀect on the structure and
dynamics of the Aβ peptide. Platinum results in extended
structures, with large displacement between the termini and
greater ﬂexibility of most residues, especially those toward the
C-terminus. Copper binding results in a mix of conformations,
adopting structures that are “platinum-like” as well as others
that are close to those for the free peptide. Secondary structure
analysis shows that both metals stabilize helices, with similar
overall quantities of this structural element. Platinum has more
310-helix whereas copper has approximately equal amounts of
310- and α-helix. The peptide regions within which these occur
also diﬀers, with copper having the majority of helices in the
central hydrophobic cluster and toward the C-terminus, while
platinum induces greatest helical content near the N-terminus.
Conformational diﬀerences are reﬂected in the diﬀering salt
bridge networks. Asp23-Lys28, which has implications in
aggregation, is signiﬁcantly altered under metal coordination.
In the free peptide this salt bridge is present in 33% of the
time, but in all frames the individual residues are in close
contact. Cu and Pt, despite having occurrences of 63% and
29%, respectively, show diﬀerent patterns: the salt bridges that
do occur have smaller distances between charged moieties, but
the remaining frames have such a large separation that it would
not be possible for the salt bridge to reoccur without major
conformational rearrangement. The Arg5-Asp7 salt bridge also
shows signiﬁcant diﬀerences when metal binding occurs,
dropping from 71% to 0% for both Cu and Pt. The binding
of the metal to the residue between this salt bridge directly
causes this diﬀerence as the charged side-chains are no longer
able to orient to form this interaction.
The diﬀering dynamical and structural observations for Cu
and Pt appear to arise from the nature of the coordination
sphere. Despite the metals sharing two coordinating residues,
the signiﬁcance of the copper also binding to one neighboring
residue and to the residue adjacent to the N-terminus, along
with the eﬀects of the bulky phenanthroline ligand, cannot be
understated. Copper binding at residues Ala2, His6, His13, and
His14 results in a more restrictive and compact coordination
sphere. In comparison, platinum binding at His6 and His14,
combined with the additional ligand, allows for a greater
backbone mobility and structural ﬂexibility for this region.
Metal binding to Aβ plays a pivotal role in the progression
and onset of AD, but at present that exact role is still largely
disputed. Understanding the diﬀerences that occur at the
coordination site and the peptide beyond, and how the
conformation and dynamics can be signiﬁcantly altered will
lead to a greater knowledge of this devastating disease.
■ METHODS
Ligand ﬁeld molecular dynamics (LFMD) simulations were carried
out using DL_POLY_LF,65 which incorporates LFMM within
DL_POLY2.0.73 LFMM parameters for Cu(II) and Pt(II) have
been tested and reported previously,66,69 while AMBER PARM94
parameters have been used for all other atoms.74 Aβ1−42 was
constructed in extended conformation within MOE,75 with the
appropriate residue protonation states for physiological pH. Cu(II)
was coordinated in a [Oc
A2,Nε
H6,Nδ
H13,Nε
H14] binding mode, while
Pt(II)-phenanthroline was coordinated in a [Nε
H6,Nε
H14] binding
mode. Partial charge assignment was carried out using MOE’s
dictionary lookup, then modiﬁcation to the metal and coordination
Figure 11. ARG5-ASP7 taken from (a) last frame of AB2, (b) last
frame of Cu3, and (c) last frame of Pt1. Phen ligand omitted for
clarity.
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sphere charges was carried out as reported previously, with values
reported in Tables S1 and S2.66,69
LowMode molecular dynamics simulations76 were carried out
within the DommiMOE60 extension to MOE to generate diverse
starting points for LFMD simulations.67 DL_POLY input ﬁles were
generated using DL_FIELD3.577 and DommiMOE, for the free
Aβ1−42 and the metal bound Aβ1−42, respectively. All LFMD
simulations were carried out within the NVT ensemble, with a 1 fs
integration time step, for 1 μs. Nose-́Hoover thermostat, with
relaxation constant of 0.5 ps, was used to control temperature at 310
K. Reaction ﬁeld electrostatics were used throughout with a van der
Waals cutoﬀ of 10 Å and long-range electrostatic interaction cutoﬀ of
21 Å. The SHAKE algorithm,78 with a tolerance of 10−8 Å, was used
to constrain all bonds to hydrogen. Atomic positions and velocities
were recorded every 10 ps for subsequent analysis.
Analysis of all the LFMD trajectories was carried out using VMD
1.9.2.79 RMSD and Rg were utilized for equilibration tests. The
timeline extension was used to analyze secondary structure (using the
STRIDE algorithm),80 RMSF, hydrogen bonds, and salt bridges.
Residue contact maps were recorded using the iTrajComp VMD
plugin.81 The presence of a hydrogen bond was determined by a
donor−acceptor distance of less than 3 Å with an angle of less than
20°. Salt bridges were deﬁned as any contact distance of less than 3.2
Å between oxygen and nitrogen atoms in charged residues.
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